Conclusion GLP-1 patches and oral supplements are not equivalent options
If the solution is significantly redder than previous vials, or if the label does not mention B12, this could indicate contamination or degradation
Feb 27 2020;18(1):104
Tirzepatide is already approved as a glucose-lowering medication in patients with type 2 diabetes (T2D) and is currently being investigated in phase-3 trials for its weight loss benefits
Clinical Results: Based on an independent clinical study with 32 subjects after 8 weeks: Clinically proven to visibly improve uneven tone, discoloration, radiance, firmness, and elasticity 94% had visibly improved discolorations 91% had brighterlooking skin For optimal results, use morning and evening
The study found that after IDH1 mutation, it will catalyze the massive conversion of 2-KG to tumor metabolite 2-HG, while consuming reduced NADPH